These observations suggested that measurement of 3H-QNB binding would provide a reliable estimate of muscarinic receptor number on cultured sympathetic neurons. To determine whether nonneuronal cells produce soluble factors that influence muscarinic receptor expression, the effects of treatment with rat fibroblast-conditioned medium (RFCM) were examined. Exposure of sympathetic neurons to 50% RFCM resulted in a 57% decrease in muscarinic receptor numbers without a change in the apparent Kd. The decrease in 3H-QNB binding in response to RFCM was dose-related, with a minimum dose of 15% RFCM required to observe a significant effect. In contrast to the carbachol-induced down-regulation, the reduction in binding after RFCM treatment was not prevented by atropine, indicating that the effect was not mediated by acetylcholine stimulation of muscarinic receptors. Binding of 1251-alpha-bungarotoxin, which labels a nonfunctional membrane site distinct from nicotinic receptors, was not altered by treatment with RFCM, indicating the selectivity of the change in membrane muscarinic receptors. Moreover, RFCM treatment increased levels of the cholinergic biosynthetic enzyme, choline acetyltransferase.
These observations suggest that the complement of receptors expressed by sympathetic neurons may be regulated by soluble factors produced by non-neuronal cells, and that transmitter and receptor phenotypes may both be regulated by factors produced by a single type of non-neuronal cell.
Developing neurons potentially may express any of a large number of transmitters and transmitter receptors, and the precise complement of traits actually expressed is influenced by neu-ronal interactions with the environment. For example, sympathetic neurons that in vivo exhibit predominantly noradrenergic traits synthesize and release acetylcholine when cultured in the presence of certain non-neuronal cells (Patterson, 1978) . Moreover, medium conditioned by exposure to non-neuronal cells, such as fibroblasts, stimulates cholinergic traits, suggesting that transmitter expression may be regulated by non-neuronal cell-derived soluble factors (Patterson and Chun, 1977) . Rat fibroblast-conditioned medium (RFCM) also stimulates levels of the neuropeptides somatostatin and substance P and their respective mRNAs, indicating that multiple transmitter systems may be simultaneously regulated by soluble factors Spiegel et al., 1986) . Other environmental cues may also influence transmitter expression: cholinergic development is promoted in cultured sympathetic neurons by neuronal contact with cell membranes (Adler and Black, 1985; Kessler et al., 1986; Wong and Kessler, 1987) whereas noradrenergic differentiation is fostered by depolarizing stimuli (Black et al., 197 1; Walicke et al., 1977) or glucocorticoids (Patterson, 1978; Fukada, 1980; McLennan et al., 1980; Sze and Hedrick, 1983) . Thus, multiple factors in the neuronal microenvironment may help determine transmitter phenotype.
Less is known about mechanisms regulating transmitter receptor expression, although it is apparent that the number of receptors expressed by cultured cells is influenced by environmental factors. For example, P-adrenergic receptor number in cultured fibroblasts (Pochet et al., 1982) , hepatocytes (Nakamura et al., 1984) , and astrocytoma cells (Harden et al., 1979) is regulated by cell density. Both the number and distribution of muscle acetylcholine receptors are regulated by soluble factors produced by CNS tissue (Jesse11 et al., 1979; Schaffner and Daniels, 1982) . In pancreatic acinar cells, the number of cholecystokinin receptors is stimulated by treatment with glucocorticoids (Logsdon, 1986) and in PC12 cells both nicotinic and muscarinic receptor numbers are elevated after nerve growth factor (NGF) treatment (Dichter et al., 1977; Jumblatt and Tischler, 1982; Amy and Bennett, 1983) . Finally, transmitters themselves may down-regulate receptor number and alter (desensitize) receptor responsiveness (see Sibley and Letkowitz, 1985) .
Is neuronal receptor expression influenced by the same microenvironmental factors that influence transmitter development? To approach this question, we sought to examine the influence on sympathetic neuron receptor development of culture conditions known to regulate transmitter expression. Sympathetic neurons contain a variety of transmitter receptors, including nicotinic, muscarinic, substance P, LY-and P-adrenergic receptors, and others (Obata, 1974; Brown and Fumagalli, 1977; Brown and Caulfield, 1979; Brown et al., 1980; Ashe and Libet, 1982; Kouvelas and Greene, 1982; Brown and Dunn, 1983; Ip and Zigmond, 1984; Ballanyi and Grafe, 1985; Brown and Selyanko, 1985; Ip et al., 1985; Niwa et al., 1985; Kiraly et al., 1986) . The choice of receptor for study in culture required that it have a relatively high membrane density of receptors, an availability of a specific high-affinity ligand, and a demonstrable biologic function in vivo. The muscarinic receptor, for which the high-affinity ligand 3H-QNB is available, met all of these criteria. Muscarinic receptors on superior cervical ganglion (SCG) neurons participate in the ganglion response to acetylcholine released from preganglionic fibers. Preganglionic stimulation in the presence of nicotinic blocking agents results in slow excitatory and slow inhibitory postsynaptic potentials that are blocked by muscarinic antagonists (Ashe and Yarosh, 1984; Cole and Shinnick-Gallagher, 1984) . Moreover, direct activation of receptors with muscarinic agonists stimulates a variety of biochemical and physiological responses in the isolated rat SCG (Hashiguchi et al., 1982; Bone et al., 1984; Brown and Selyanko, 1985; Cahill and Perlman, 1985; Horwitz et al., 1986) . Consequently, we examined the regulation of muscarinic receptors in cultured sympathetic neurons. Alpha-bungarotoxin (a-BTX) binding sites, which are present in the SCG but have no known function, were measured as a control for nonspecific changes in neuronal cell membranes.
We report that RFCM, which promotes cholinergic transmitter expression, significantly reduces muscarinic receptor number, suggesting that transmitter and receptor traits in sympathetic neurons may both be regulated by the neuronal microenvironment.
Materials and Methods
Materials. Tissue culture media, penicillin, streptomycin, trypsin, and fetal bovine serum were obtained from Gibco. NGF was prepared in our laboratory according to the method of Mobley et al. (1976) . Cytosine-@-D-arabinofuranoside (Ara C), atropine, carbachol, oxotremorine, muscarine, hexamethonium, and nicotine were purchased from Sigma Chemical Company (St. Louis, MO). Pirenzipine was the kind gift of Karl Thomae, W. Germany.
Experimental animals. Pregnant Sprague-Dawley rats (CAMM) were housed in clear plastic and wire cages and were exposed to 650-800 lux of cool white illumination from 5 AM to 7 PM daily. Ralston Purina lab chow and water were offered ad libitum. Neonates were routinely used within 24 hr after delivery, and were killed by a blow to the head immediately prior to the removal of the SCG.
Tissue culture techniques. SCGs from neonatal rats were treated with trypsin (0. lo/o), mechanically dissociated, and plated on a rat-tail collagen substratum, as previously described (Kessler et al., 1984) . Growth medium consisted of Ham's nutrient mixture F12 with 10% heat-inactivated fetal bovine serum (F 12FCS lo), NGF (100 @ml), penicillin (50 U/ml), and streptomycin (50 &ml). Cultures were maintained at 37°C in a humidified 95% sir/5% CO, atmosphere. Ganglion non-neuronal cells were eliminated by treatment with Ara C (5 PM) on days 1 and 3 of culture. Cultures were fed 3 times/week, experimental treatments were begun on day 2 with the first feeding and were continued for a total of 14 to 16 d before harvesting.
Preparation of ratfibroblast-conditioned medium. Skin samples from embryonic rats (E17) were treated with trypsin, mechanically dissociated, and plated on tissue culture plastic in Eagle's minimal essential medium containing 15% fetal bovine serum. Fibroblasts were allowed to grow to confluence in this medium, which minimized the survival of other cell types; at the first passage, the feeding medium was switched to F12FCS 10 so that it could be used to treat neuronal cultures. Medium collected from confluent cultures (RFCM) was filtered (0.45 pm; Millipore) and mixed with various percentages of fresh medium for treatment of SCG cultures. Unused RFCM was stored at -20°C.
Preparation of tissue from cultured SCG neurons. Neuron numbers in each culture were determined by counting representative areas, as previously described (Kessler, 1985) . Cultures were rinsed in ice-cold assay buffer (40 mM sodium/potassium phosphate, pH 7.4) and harvested by scraping with a rubber policeman into a small volume of buffer. Samples were homogenized with a Polytron (Brinkman; setting 5y2, 10 set) and collected by centrifugation at 4°C (39,000 x g; 15 min). The pellets were washed twice and resuspended in ice-cold assay buffer at approximately 100 pg protein/ml, and were kept cold until use that day. Protein was determined by the method of Bradford (1976) .
Muscarinic binding assay. Binding assays were carried out in 40 mM sodium/potassium phosphate, pH 7.4, at 25°C for 1 hr. Varying concentrations of 1-quinuclidinyl [phenyl-4JH] benzilate ('H-QNB, 3046 Ci/mmol; Amersham) were incubated with -10 pg tissue protein in a total volume of either 1 or 2 ml in 12 x 75 mm glass tubes. Nonsnecific binding was determined in the presence of 1 oh atropine. Incubation was terminated by rapid filtration (Cell Harvester, Brandel) over GF/B glass-fiber filters (Whatman), followed by rinsing with 3 x 5 ml of icecold assay buffer. Filters were placed in scintillation vials and were allowed to sit overnight in 10 ml scintillation cocktail (Hydrofluor; National Diagnostics) before being counted in a Packard liauid-scintillation counter at 50-35% efficiency.
a-BTX binding assay. Tissue from SCG cultures was prepared as described, except that samples were collected and homogenized in PBS (10 mM sodium/potassium phosphate, 145 mM NaCl), pH 7.4. Binding assays were carried out in PBS, pH 7.4 containing 0.1% BSA at 25°C for 3 hr. lz51-~-BTX was incubated with -50 pg tissue protein in 12 x 75 mm polypropylene tubes in a total -volume of 250 ~1. The final concentration of lz51-~-BTX was 5 nM; nonspecific binding was determined in the presence of 5 FM unlabeled LU-BTX. Incubation was terminated by rapid filtration over GF/B filters oresoaked in 0.1% nolv-. < ethylenimine (PEI), followed by rinsing with 4 x 5 ml ice-cold assay buffer. Filters were counted immediately in a Packard Gamma Counter at 90-95% efficiency.
Data analysis. Data from saturation and inhibition curves were analyzed by computer, using a modification of the nonlinear least-squares regression program, LIGAND (Munson and Rodbard, 1980) . Enzyme assays. Details of enzymatic assays for choline acetyltransferase (CAT) and tyrosine hydrcxylase have been reported previously (Kessler and Black, 1979; Kessler, 1985) .
Results
To define the characteristics of muscarinic receptors on cultured sympathetic neurons, the nonselective lipophilic muscarinic antagonist 3H-QNB was used as a radioligand in receptor binding assays. Saturation isotherms obtained by varying the concentration of the labeled ligand ( Fig. 1) show that specific binding to washed homogenates of 2-week-old sympathetic neuron cultures increased sharply between 0.01 and 0.1 nM 3H-QNB and reached saturation at 0.5 nM, representing at least 75% of total binding at all concentrations tested. In contrast, nonspecific binding increased in a nonsaturable fashion that was linear with 3H-QNB concentration (Fig. 1) . Scatchard transformation (Fig. 2) of the saturation data shown in Figure 1 reveals that 3H-QNB bound to one apparent class of noninteracting sites with a Kd of 28.9 f 2.4 PM and a B,,, of 2.91 + 0.6 pmol/ mg protein (mean f SEM; n = 6), as determined by linear regression analysis. This low Kd value, corresponding to highaffinity binding, agrees well with published values for 3H-QNB binding to other membrane preparations (Nathanson, 1983) . Specific binding of 3H-QNB increased as a linear function of tissue protein and remained linear up to a concentration of 35 pg protein/ml, the highest tested (Fig. 3) , indicating that changes in specific binding are good estimates of changes in receptor concentration under these conditions. The pharmacological specificity of the site was examined using various unlabeled drugs as inhibitors of 3H-QNB binding (Fig. 4) . The selective muscarinic agonists oxotremorine and muscarine each inhibited 3H-QNB binding with an IC,, in the micromolar range (2.6 and 3.1 PM, respectively, with Hill coefficients n, = 0.7), and the IC,, for the cholinergic agonist carbachol was 43 PM (n, = 0.4). In contrast to the muscarinic agonists, the nicotinic ligands nicotine and hexamethonium were much less potent (IC,,s = 0.14 and 0.89 mM, respectively), confirming the selectivity of QNB for muscarinic sites. The classical antagonist atropine (mean IC,, = 7.6 + 1 .O nM; mean Hill coefficient, 1.01; II = 2) was a more potent inhibitor than pirenzipine, a selective Ml antagonist (IC,, = 2.0 k 0.8 PM; n = 2). It is likely that a mixture of muscarinic receptor subtypes was present, since the Hill coefficient for pirenzipine was 0.8. To determine whether these muscarinic sites could be downregulated by exposure to agonist, as has been demonstrated in other systems (Siman and Klein, 1981; Champion and Mauchamp, 1982) , cultures were treated with various doses of carbachol and assayed for 3H-QNB binding after 2 weeks. As shown in Figure 5 , chronic treatment with carbachol resulted in a 55-65% decrease in muscarinic binding at doses above 1 FM.
The development of muscarinic binding with time in culture was examined (Fig. 6) . Membrane protein levels increased steadily with time in culture, coincident with an observed pro- liferation of neurites (data not shown). However, muscarinic binding increased more than 4-fold on a per-milligram protein basis between days 2 and 7 in culture, then increased proportionally with protein. The total number of receptors increased from 0.5 pmol/mg protein in the neonatal ganglion before culturing to 2.9 pmol/mg protein in 16 d pure neuronal cultures (Fig. 6 ).
Effects of RFCM on muscarinic binding
The transmitter phenotype of cultured sympathetic neurons depends on the physiologic state and environment of the neuron (Patterson, 1978; Black, 1982; Kessleret al., 1983) . For example, culture of sympathetic neurons in the presence of RFCM promotes the expression of cholinergic traits (Patterson and Chun, 1977) . To determine whether the receptor phenotype is also influenced by the environment, muscarinic binding of neurons cultured in the presence of RFCM was examined. Treatment of dissociated SCG neurons with 50% RFCM for 2 weeks resulted in a 57% decrease in specific 3H-QNB binding, from a mean of 1.3 1 f 0.14 to 0.56 + .06 pmol/mg protein (n = 3; Fig. 7) , with no significant change in neuron number. Figure 8 shows that RFCM inhibited binding in a dose-related fashion. The minimum dose of RFCM required to observe a significant effect was 15%, and the concentration required to inhibit half the binding was approximately 40%. To determine whether the decrease in binding was due to a change in the affinity for the ligand or in the total number of binding sites, Scatchard analyses of saturation binding experiments were performed. As is seen in Figure 9 , the decrease in binding after treatment with 30% RFCM for 2 weeks was due to a decrease in B,,, from 3.4 1 pmol/mg protein to 1.98 pmol/ mg protein, with no significant change in Kd (control, 28.4 PM; RFCM, 35.9 PM) . Since neuron numbers were unchanged by treatment with RFCM, the observed changes in muscarinic binding did not . Effect of RFCM treatment of SCG cultures on 0.5 nM 'H-QNB binding. Cultures were grown for 2 weeks either in control medium or medium containing 50% RFCM before harvesting for )H-QNB binding. Bars represent mean -I SEM; n = 3. Binding to RFCM cultures differs from control at p < 0.01 (2-tailed t test). Neuron numbers were not significantly affected by the treatment.
reflect death of subpopulations of neurons. However, to exclude the possibility that the reduction in QNB binding was due to a nonspecific toxic effect of RFCM, several other biochemical traits were examined. In agreement with previous reports (Patterson and Chun, 1977; Kessler, 198 5) activity of the cholinergic biosynthetic enzyme (CAT) was greatly increased in cultures treated with 50% RFCM, while activity of tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis, was unchanged (Table 1) . RFCM treatment also caused large increases in levels of the neuropeptides somatostatin and substance P, and in their respective mRNA levels Werner and Spiegel et al., 1986) . To control for the possibility that RFCM treatment nonselectively altered neuron membranes, we examined the binding of rz51-ol-BTX. The SCG contains abundant ar-BTX binding sites that are not, however, functional receptors (Obata, 1974; Carbonetto et al., 1976; Ko et al., 1976; Brown and Fumagalli, 1977) as membrane surface area or neurite extension were altered by RFCM treatment, we would expect to see an alteration in o(-BTX binding sites. As shown in Figure 10 , treatment of cultures with 30% RFCM had no significant effect on specific 1251-ol-BTX binding. Lower doses of RFCM also had no effect (data not shown). These findings demonstrate that RFCM treatment causes a spectrum of selective phenotypic changes, including increases in several specific transmitter systems, as well as a decrease in muscarinic receptor number.
Since CAT activity and acetylcholine synthesis (Patterson and Chun, 1977) are elevated by treatment with RFCM, the decrease in muscarinic binding could have reflected agonist-induced downregulation due to increased acetylcholine release, similar to the effect of carbachol shown in Figure 5 . To determine whether this mechanism mediated the change in QNB binding, experiments using atropine as a potential blocker were performed. Cultures were treated with either 10m5 M carbachol or 15% RFCM in the presence and absence of 10m6 M atropine. As shown in Figure 11 , the -70% reduction in binding caused by carbachol was completely prevented by concurrent treatment with atropine, while atropine alone had no effect. By contrast, the 32% reduction in binding after RFCM treatment was not sensitive to atropine, indicating that muscarinic receptor activation by acetylcholine was not responsible for the effect. (Siman and Klein, 1981; Sibley et al., 1987) . Moreover, CNS tissue produces soluble factors that increase numbers of acetylcholine receptors in muscle and sympathetic neurons, and that promote clustering of receptors (Jesse11 et al., 1979; Schaffner and Daniels, 1982; Leah et al., 1986) . It is not known whether these factors are produced by the presynaptic neurons or by non-neuronal cells. Receptor numbers are also subject to hormonal regulatory influences. For example, glucocorticoids increase cholecystokinin receptor levels in cultured pancreatic acinar cells (Logsdon, 1986) and increase insulin receptor number in mouse fibroblasts (Knutson, 1986) . Other potential regulatory factors include polypeptide growth Specific Bound factors (Askanas et al., 1985) and gangliosides (Berry-Kravis and Dawson, 1985) . Thus, there are a large number of potential regulatory signals governing receptor development. The present study used a well-defined culture system with a relatively homogeneous population of neurons to begin to rigorously define mechanisms mediating influences of the environment on neuronal membrane receptors. Since transmitter development in cultured rat sympathetic neurons has been extensively investigated (Patterson, 1978; Black, 1982; Kessler, 1985) the present study facilitated comparison of the effects of the environment on both receptor and transmitter development.
Muscarinic receptors in sympathetic neurons Sympathetic neurons in the SCG contain large numbers of both nicotinic and muscarinic receptors. Since the high-affinity muscarinic ligand 3H-QNB labeled receptors in cultured neurons at levels high enough to allow practical binding studies in culture, we examined muscarinic receptor development. Muscarinic receptors participate in the SCG response to input from preganglionic fibers in vivo. Preganglionic stimulation in the presence of nicotinic blocking agents results in slow postsynaptic potentials that are inhibited by muscarinic antagonists (Ashe and Yarosh, 1984) . Direct activation of the receptors with muscarinic agonists alters sympathetic neuron membrane currents (Hashiguchi et al., 1982; Brown and Selyanko, 1985) , increases inositol phosphate metabolism (Bone et al., 1984; Horwitz et al., 1986) , and increases phosphorylation of tyrosine hydroxylase (Cahill and Perlman, 1985) in SCG neurons. Thus, muscarinic receptors influence several physiological functions of SCG neurons. Nevertheless, relatively little is known about the regulation of muscarinic receptors in the SCG. Preganglionic denervation of the SCG increased muscarinic receptor number in cats (Taniguchi et al., 1983) , but had no effect in rats (Burt, 1978) . By contrast, postganglionic axotomy diminished muscarinic receptor binding (Sinicropi et al., 1979) , suggesting that target-related factors may be important in regulating receptor number. NGF treatment of ganglion explants prevented a decrease in the muscarinic binding found in control cultures, which suggests that NGF could mediate some of the target-related effects on receptor number (Dombrowski et al., 1983) . NGF treatment of PC1 2 pheochromocytoma cells increased muscarinic receptor binding (Jumblatt and Tischler, 1982) . Agonistinduced down-regulation of muscarinic receptors has been well characterized in several systems (Siman and Klein, 198 1; Champion and Mauchamp, 1982) as well as in this study (Fig. 5) . Finally, glucocorticoid treatment did not alter muscarinic binding in SCG explants, suggesting that the hormone is not involved in regulating muscarinic receptor development in sympathetic neurons (Dombrowski et al., 1983) .
suggest that the 3H-QNB binding sites represent functional receptors, that the receptors in culture are similar to those in more intact systems, and that regulation of muscarinic receptors can be appropriately studied using dissociated neuron cultures of the SCG.
Regulation of muscarinic receptors by non-neuronal cells Treatment of sympathetic neurons with RFCM significantly decreased 3H-QNB binding in a dose-dependent manner. Scatchard analysis of saturation curves demonstrated that the decrease in binding reflected a reduction in the total number of receptors rather than a change in the affinity for the ligand. By contrast, RFCM treatment had no effect on the binding of lZ51-cu-BTX, demonstrating the selectivity of the effect on muscarinic binding. Moreover, treatment with RFCM increased neuronal levels of CAT (Table 1) and somatostatin, as previously reported (Patterson and Chun, 1977; Spiegel et al., 1986) , indicating that stimulatory, as well as inhibitory, effects were exerted on neuronal phenotypic expression. The reduction in binding after RFCM treatment was unaffected by concurrent treatment with atropine, unlike the down-regulation due to carbachol, which was prevented by the antagonist. This suggests that a mechanism other than direct muscarinic receptor activation was responsible for the decrease in receptor number. Current studies are directed towards defining the precise mechanism underlying the effects of RFCM. The prominent effects of RFCM on both transmitter expression and muscarinic receptor number suggest that transmitter and receptor development may be simultaneously regulated by the neuronal microenvironment.
RFCM contains multiple proteins shed by fibroblasts, so it is not yet known whether the same molecule exerts effects on both transmitters and receptors. Nevertheless, it is clear that soluble factors produced by a single type of non-neuronal cell may regulate both transmitter and receptor development. If both the presynaptic and postsynaptic neurons at a synapse were responsive to non-neuronal-derived soluble factors, then such factors could help coordinate the match between presynaptic neuronal expression of transmitter and postsynaptic neuronal receptor expression. Human, calf, and rat brains contain a factor similar or identical to the cholinergicpromoting factor in RFCM ; thus, neurons in the brain, as well as in the periphery, may be regulated by the factor. It is interesting that RFCM down-regulated muscarinic cholinergic receptors, but at the same time stimulated cholinergic transmitter expression. We are currently examining the effects of RFCM on other receptors, including nicotinic and substance P receptors, to determine whether some of them are stimulated by the treatment.
In this study we found that cultures of dissociated sympathetic neurons had specific, saturable, high-affinity binding sites for 3H-QNB (Figs. 1, 2) . Moreover, these sites exhibited pharmacologic specificity for muscarinic ligands, with higher affinity for the classical antagonist atropine than for agonists, as is commonly observed (Aguilar et al., 1982; Champion and Mauchamp, 1982; Jumblatt and Tischler, 1982; Watson et al., 1986) . Multiple subtypes of muscarinic receptors were probably present, since inhibition of 3H-QNB binding by the selective Ml antagonist pirenzipine yielded a Hill coefficient of less than 1. Using patch-clamp techniques in collaboration with Dr. D. Brosius, we observed muscarinic currents in the cultured sympathetic neurons (Brosius et al., 1986) . In toto, these observations
